Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
24 Luglio 2024 - 11:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
| | | | | |
Filed by the Registrant x |
Filed by a Party other than the Registrant o |
| Check the appropriate box: |
| o | Preliminary Proxy Statement |
| o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| o | Definitive Proxy Statement |
| x | Definitive Additional Materials |
| o | Soliciting Material under §240.14a-12 |
| | |
| Context Therapeutics Inc. |
| (Name of Registrant as Specified In Its Charter) |
|
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
| | | | | | | | |
| Payment of Filing Fee (Check all boxes that apply): |
| x | No fee required |
| o | Fee paid previously with preliminary materials |
| o | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Grafico Azioni Context Therapeutics (NASDAQ:CNTX)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Context Therapeutics (NASDAQ:CNTX)
Storico
Da Dic 2023 a Dic 2024
